BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 30585305)

  • 1. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments.
    van Zuuren EJ; Fedorowicz Z; Tan J; van der Linden MMD; Arents BWM; Carter B; Charland L
    Br J Dermatol; 2019 Jul; 181(1):65-79. PubMed ID: 30585305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for rosacea.
    van Zuuren EJ; Fedorowicz Z; Carter B; van der Linden MM; Charland L
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003262. PubMed ID: 25919144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments.
    van Zuuren EJ; Fedorowicz Z
    Br J Dermatol; 2015 Sep; 173(3):651-62. PubMed ID: 26099423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosacea: An Update in Diagnosis, Classification and Management.
    Kang CN; Shah M; Tan J
    Skin Therapy Lett; 2021 Jul; 26(4):1-8. PubMed ID: 34347259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for rosacea.
    van Zuuren EJ; Kramer S; Carter B; Graber MA; Fedorowicz Z
    Cochrane Database Syst Rev; 2011 Mar; (3):CD003262. PubMed ID: 21412882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review.
    van Zuuren EJ; Kramer SF; Carter BR; Graber MA; Fedorowicz Z
    Br J Dermatol; 2011 Oct; 165(4):760-81. PubMed ID: 21692773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S2k guideline: Rosacea.
    Clanner-Engelshofen BM; Bernhard D; Dargatz S; Flaig MJ; Gieler U; Kinberger M; Klövekorn W; Kuna AC; Läuchli S; Lehmann P; Nast A; Pleyer U; Schaller M; Schöfer H; Steinhoff M; Schwennesen T; Werner RN; Zierhut M; Reinholz M
    J Dtsch Dermatol Ges; 2022 Aug; 20(8):1147-1165. PubMed ID: 35929658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosacea: New Concepts in Classification and Treatment.
    van Zuuren EJ; Arents BWM; van der Linden MMD; Vermeulen S; Fedorowicz Z; Tan J
    Am J Clin Dermatol; 2021 Jul; 22(4):457-465. PubMed ID: 33759078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosacea: a review of current topical, systemic and light-based therapies.
    Kennedy Carney C; Cantrell W; Elewski BE
    G Ital Dermatol Venereol; 2009 Dec; 144(6):673-88. PubMed ID: 19907406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosacea management: A comprehensive review.
    Sharma A; Kroumpouzos G; Kassir M; Galadari H; Goren A; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 May; 21(5):1895-1904. PubMed ID: 35104917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rosacea: New data for better care].
    Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):508-517. PubMed ID: 28728857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosacea: update on management and emerging therapies.
    Fallen RS; Gooderham M
    Skin Therapy Lett; 2012 Dec; 17(10):1-4. PubMed ID: 23223767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosacea and rhinophyma.
    Tüzün Y; Wolf R; Kutlubay Z; Karakuş O; Engin B
    Clin Dermatol; 2014; 32(1):35-46. PubMed ID: 24314376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical and oral therapeutic approach to rosacea.
    Helfrich YR; Maier LM
    Semin Cutan Med Surg; 2016 Jun; 35(2):74-8. PubMed ID: 27416312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Combination Laser or Intense Pulsed Light Therapies and Doxycycline for the Treatment of Rosacea.
    Schilling LM; Halvorson CR; Weiss RA; Weiss MA; Beasley KL
    Dermatol Surg; 2019 Nov; 45(11):1401-1405. PubMed ID: 31658188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Clinical Practice Guidelines for Rosacea.
    Asai Y; Tan J; Baibergenova A; Barankin B; Cochrane CL; Humphrey S; Lynde CW; Marcoux D; Poulin Y; Rivers JK; Sapijaszko M; Sibbald RG; Toole J; Ulmer M; Zip C
    J Cutan Med Surg; 2016 Sep; 20(5):432-45. PubMed ID: 27207355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosacea: where are we now?
    Bikowski JB; Goldman MP
    J Drugs Dermatol; 2004; 3(3):251-61. PubMed ID: 15176158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosacea Management: Update on general measures and topical treatment options.
    Schaller M; Schöfer H; Homey B; Hofmann M; Gieler U; Lehmann P; Luger TA; Ruzicka T; Steinhoff M
    J Dtsch Dermatol Ges; 2016 Dec; 14 Suppl 6():17-27. PubMed ID: 27869379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.